NJ Governor Expected To Sign Medical Marijuana Expansion Into Law July 2

MM
Montgomery McCracken Walker & Rhoads LLP

Contributor

Montgomery McCracken Walker & Rhoads LLP
If signed, this law would expand the State of New Jersey's medical marijuana program.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On June 28, 2019, New Jersey Governor Phil Murphy stated that he will sign the Jake Honig Compassionate Use Medical Cannabis Act (A20) into law on July 2. If signed, this law would expand the State of New Jersey's medical marijuana program. A20 would create a new five-member Cannabis Regulatory Committee to oversee the state's medical marijuana program. A20 also allows for additional alternative treatment centers, which may provide cultivation, manufacturing or dispensing, rather than all three, which was previously required. A20 also phases out the state sales tax on medical marijuana cutting it from 6.625 percent to 4 percent on July 1, 2020, then to 2 percent on July 1, 2021.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

NJ Governor Expected To Sign Medical Marijuana Expansion Into Law July 2

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Montgomery McCracken Walker & Rhoads LLP
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More